Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 4
2020 6
2021 4
2022 4
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
ESMO management and treatment adapted recommendations in the COVID-19 era: gynaecological malignancies.
Colombo I, Zaccarelli E, Del Grande M, Tomao F, Multinu F, Betella I, Ledermann JA, Gonzalez-Martin A, Sessa C, Colombo N. Colombo I, et al. Among authors: betella i. ESMO Open. 2020 Jul;5(Suppl 3):e000827. doi: 10.1136/esmoopen-2020-000827. ESMO Open. 2020. PMID: 32718919 Free PMC article. Review.
To manage patients with cancer adequately, maintaining the highest quality of care, a definition of value-based priorities is necessary to define which interventions can be safely postponed without affecting patients' outcome. The European Society for Medical Oncology (ESM …
To manage patients with cancer adequately, maintaining the highest quality of care, a definition of value-based priorities is necessary to d …
Clinicopathological characteristics of multiple-classifier endometrial cancers: a cohort study and systematic review.
De Vitis LA, Schivardi G, Caruso G, Fumagalli C, Vacirca D, Achilarre MT, Aloisi A, Garbi A, Zanagnolo V, Aletti G, Guerini-Rocco E, Mariani A, Maggioni A, Barberis M, Bogani G, Colombo N, Multinu F, Betella I. De Vitis LA, et al. Among authors: betella i. Int J Gynecol Cancer. 2023 Dec 22:ijgc-2023-004864. doi: 10.1136/ijgc-2023-004864. Online ahead of print. Int J Gynecol Cancer. 2023. PMID: 38135437
METHODS: Multiple classifiers identified at the European Institute of Oncology, Milan, between April 2019 and Decmber 2022, were included. ...
METHODS: Multiple classifiers identified at the European Institute of Oncology, Milan, between April 2019 and Decmber 2022, were incl …
Characteristics and outcomes of surgically staged multiple classifier endometrial cancer.
Bogani G, Betella I, Multinu F, Casarin J, GhezzI F, Sorbi F, VizziellI G, Petrillo M, Cianci S, Berretta R, PaolinI B, FanfanI F, De Vitis L, Scambia G, Mariani A, Colombo N, Raspagliesi F. Bogani G, et al. Among authors: betella i. Eur J Surg Oncol. 2024 Jan;50(1):107269. doi: 10.1016/j.ejso.2023.107269. Epub 2023 Nov 15. Eur J Surg Oncol. 2024. PMID: 37984242
Microsatellite instability evaluation: which test to use for endometrial cancer?
Rafaniello-Raviele P, Betella I, Rappa A, Vacirca D, Tolva G, Guerrieri-Gonzaga A, Bertario L, Barberis M, Bonanni B, Marabelli M. Rafaniello-Raviele P, et al. Among authors: betella i. J Clin Pathol. 2023 Jan;76(1):29-33. doi: 10.1136/jclinpath-2021-207723. Epub 2021 Jul 26. J Clin Pathol. 2023. PMID: 34312297
A novel algorithm to implement the molecular classification according to the new ESGO/ESTRO/ESP 2020 guidelines for endometrial cancer.
Betella I, Fumagalli C, Rafaniello Raviele P, Schivardi G, De Vitis LA, Achilarre MT, Aloisi A, Garbi A, Maruccio M, Zanagnolo V, Aletti G, Guerini-Rocco E, Mariani A, Maggioni A, Barberis M, Colombo N, Multinu F. Betella I, et al. Int J Gynecol Cancer. 2022 Jun 22:ijgc-2022-003480. doi: 10.1136/ijgc-2022-003480. Online ahead of print. Int J Gynecol Cancer. 2022. PMID: 35732351
OBJECTIVE: To compare the risk class attribution with molecular classification unknown to those with molecular classification known, according to the European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Patho …
OBJECTIVE: To compare the risk class attribution with molecular classification unknown to those with molecular classification known, accordi …
Inhibition of the Wnt/β-catenin pathway enhances antitumor immunity in ovarian cancer.
Doo DW, Meza-Perez S, Londoño AI, Goldsberry WN, Katre AA, Boone JD, Moore DJ, Hudson CT, Betella I, McCaw TR, Gangrade A, Bao R, Luke JJ, Yang ES, Birrer MJ, Starenki D, Cooper SJ, Buchsbaum DJ, Norian LA, Randall TD, Arend RC. Doo DW, et al. Among authors: betella i. Ther Adv Med Oncol. 2020 Apr 14;12:1758835920913798. doi: 10.1177/1758835920913798. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 32313567 Free PMC article.
In-house testing for homologous recombination repair deficiency (HRD) testing in ovarian carcinoma: a feasibility study comparing AmoyDx HRD Focus panel with Myriad myChoiceCDx assay.
Fumagalli C, Betella I, Ranghiero A, Guerini-Rocco E, Bonaldo G, Rappa A, Vacirca D, Colombo N, Barberis M. Fumagalli C, et al. Among authors: betella i. Pathologica. 2022 Aug;114(4):288-294. doi: 10.32074/1591-951X-791. Pathologica. 2022. PMID: 36136896 Free PMC article.
21 results